Immunology and Microbiology
Urinary Tract
100%
Uropathogenic Escherichia Coli
96%
Staphylococcus Aureus
62%
Porcine Model
49%
Escherichia coli
49%
Severe Acute Respiratory Syndrome Coronavirus 2
45%
Biofilm
34%
COVID-19
26%
Neutralization
23%
Pig
20%
Omicron Coronavirus Variant
15%
Infectious Agent
15%
Filamentation
14%
Fimbria
13%
Animal Experiment
13%
Micturition
11%
Antimicrobial Resistance
10%
Monoclonal Antibody
10%
Inoculum
9%
Blood Plasma
9%
Booster Dose
9%
Cytotoxicity
9%
Low Drug Dose
9%
Macrophage
8%
Colony Forming Unit S
8%
Antibacterial Activity
8%
Abdominal Pressure
8%
Mediator
8%
Urine Sampling
8%
Viral Load
7%
Bacterial Count
7%
Complement Lectin Pathway
7%
Complement Activation
7%
Dynamics
7%
Minimum Inhibitory Concentration
7%
Immunocompromised Patient
6%
Thioridazine
6%
Antimicrobial Peptides
6%
Breed
6%
Raman Spectroscopy
6%
Aspergillus
6%
4 [3 (1h Tetrazol 5 Yl) 8 Coumarinyloxy]butyric Acid
6%
Biomechanics
6%
Matrix Protein
6%
Alpha-2-Macroglobulin
6%
Bladder Emptying
6%
Bone Structure
6%
Medline
6%
Bladder Mucosa
6%
Antibiotic Sensitivity
6%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
34%
Staphylococcus Aureus
26%
Infection
25%
Antiinfective Agent
22%
Opiate Peptide
20%
Prodrug
20%
Escherichia coli
15%
Thioridazine
13%
Dicloxacillin
13%
Antibiotics
13%
Effusion
10%
P-Glycoprotein
10%
Antivirus Agent
10%
Antibacterial Activity
9%
CYP3A4
9%
Immunocompromised Patient
9%
Uropathogenic Escherichia Coli
8%
Porcine Model
8%
Drug Delivery System
8%
Digestant
8%
Bloodstream Infection
8%
Surgical Infection
6%
Graft Infection
6%
Urinary Tract Infection
6%
Aspergillus
6%
Fucoidan
6%
RNA 23S
6%
Pleuromutilin Antibiotic Agent
6%
Enkephalin[2 Dextro Alanine 5 Dextro Leucine]
6%
Staphylococcal Infection
6%
Malignant Neoplasm
6%
Ovine Model
6%
Hyperplasia
6%
Polypeptide Antibiotic Agent
6%
Laminaria
6%
Peptidomimetic Agent
6%
Povidone
6%
1 Vinyl 2 Pyrrolidinone
6%
Glycoprotein
6%
Absorption-Distribution-Metabolism-Excretion Toxicity
6%
Blood-Brain Barrier
6%
Pharmacokinetics
6%
Pleuromutilin
6%
Plasma Protein Binding
6%
Bioavailability
6%
Cytotoxicity
6%
Gram Positive Infection
6%
Messenger RNA
6%
Monotherapy
6%
Remdesivir
6%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Urinary Tract Infection
23%
Bladder
22%
Urinary Tract
17%
Infection
15%
COVID-19
14%
Immunocompromised Patient
13%
Drug Delivery System
13%
Injury
9%
Ex Vivo
9%
Urinary System
8%
Residual Urine
8%
Microtrauma
8%
Residual Volume
8%
Antiinfective Agent
7%
In Vitro
7%
Mitomycin
6%
Surgical Infection
6%
Catheterization
6%
Urination
6%
Virus Shedding
6%
Alpha 2 Macroglobulin
6%
Mediator
6%
Diabetic Nephropathy
6%
Mesangial Cell
6%
Kidney Tissue
6%
Micturition
5%
